Neal S. Kleiman

Showing 1-1 of 1 articles

Interventions for valvular disease

One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial

Serruys P, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, Chang Y, Kleiman NS, Lilly S, Amrane H, Boonstra P, Kappetein AP, Onuma Y, Søndergaard L, Van Mieghem N

October 19, 2018 | 10.4244/EIJ-D-18-00460

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: Transcatheter treatment of multivalvular heart disease

Cardioband after placement of 17 screws before and after

Balancing risks and benefits of LM revascularisation strategies in CKD patients

Gennaro Giustino

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Contained annulus ruptures – the price to pay for optimal haemodynamic results?

Fabian Nietlispach

This week's JAA's: Right pulmonary artery to left atrium fistula, BRS in high-risk patients

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke